Scholarlink

<p>The oxidative stress response during renal crystal recurrence and the dynamics of calcium oxalate (CaOx) crystal formation and clearance in a glyoxylate (GOX)-induced mouse model were examined. CaOx crystals gradually accumulated during five consecutive days of GOX administration, decreased by half in the ten days after administration, and required five weeks for near-complete clearance. HO-1 expression was strongly induced by the initial GOX administration through Nrf2 activation but diminished on continuing the administration. When GOX was readministered after a 10-day interval, HO-1 induction was minimal; however, after a 5-week interval, HO-1 expression returned to its initial levels. Readministration of GOX after crystal clearance resulted in reduced crystal formation and individual differences in crystal volume compared with the initial episode. Preadministration of bardoxolone methyl (Bard), a potent Nrf2 activator, significantly suppressed recurrent CaOx crystal formation. These findings strongly suggest the existence of an interaction between oxidative stress responses and renal crystal recurrence, highlighting the potential of Nrf2 activation as a preventive strategy for recurrent stone formation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bardoxolone methyl (Bard)-mediated strong suppression of calcium oxalate crystal formation in renal crystal recurrence model

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月27日

查看全文
  • Chiharuko Ushimoto,
  • Ryoko Akai,
  • Shigeru Sugiki,
  • Kenshiro Kunii,
  • Shinya Inoue,
  • Takao Iwawaki,
  • Katsuhito Miyazawa

摘要

The oxidative stress response during renal crystal recurrence and the dynamics of calcium oxalate (CaOx) crystal formation and clearance in a glyoxylate (GOX)-induced mouse model were examined. CaOx crystals gradually accumulated during five consecutive days of GOX administration, decreased by half in the ten days after administration, and required five weeks for near-complete clearance. HO-1 expression was strongly induced by the initial GOX administration through Nrf2 activation but diminished on continuing the administration. When GOX was readministered after a 10-day interval, HO-1 induction was minimal; however, after a 5-week interval, HO-1 expression returned to its initial levels. Readministration of GOX after crystal clearance resulted in reduced crystal formation and individual differences in crystal volume compared with the initial episode. Preadministration of bardoxolone methyl (Bard), a potent Nrf2 activator, significantly suppressed recurrent CaOx crystal formation. These findings strongly suggest the existence of an interaction between oxidative stress responses and renal crystal recurrence, highlighting the potential of Nrf2 activation as a preventive strategy for recurrent stone formation.